Modified therapy with 5‐fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer
作者： Andre M. Murad , Flavia F. Santiago , Andy Petroianu , Paulo R. S. Rocha , Marco A. G. Rodrigues
DOI: 10.1002/1097-0142(19930701)72:1<37::AID-CNCR2820720109>3.0.CO;2-P
关键词:
摘要: … An EORTC Gastrointestinal Group phase Ill evaluation of combinations of methyl-CCNU, 5 fluorouracil and Adriamycin in advanced gastric cancer. ] Clin Oncol 1987; 5:1387-93. Cazap …
sci-hub.se 参考文章(17)
James S. Clarke, Kenneth Cruze, Sabri El Farra, William P. Longmire, The natural history and results of surgical therapy for carcinoma of the stomach. An analysis of 250 cases. American Journal of Surgery. ,vol. 102, pp. 143- 152 ,(1961) , 10.1016/0002-9610(61)90378-6
P Preusser, H Wilke, W Achterrath, U Fink, L Lenaz, A Heinicke, J Meyer, H J Meyer, H Buente, Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer. Journal of Clinical Oncology. ,vol. 7, pp. 1310- 1317 ,(1989) , 10.1200/JCO.1989.7.9.1310
J A Wils, H O Klein, D J Wagener, H Bleiberg, H Reis, F Korsten, T Conroy, M Fickers, S Leyvraz, M Buyse, Sequential high-dose methotrexate and fluorouracil combined with doxorubicin: A step ahead in the treatment of advanced gastric cancer: a trial of the European organization for research and treatment of cancer gastrointestinal tract cooperative group Journal of Clinical Oncology. ,vol. 9, pp. 827- 831 ,(1991) , 10.1200/JCO.1991.9.5.827
E. L. Kaplan, Paul Meier, Nonparametric Estimation from Incomplete Observations Springer Series in Statistics. ,vol. 53, pp. 319- 337 ,(1992) , 10.1007/978-1-4612-4380-9_25
Nelson Campos-Filho, Eduardo LF Franco, None, Microcomputer-assisted univariate survival data analysis using Kaplan-Meier life table estimators. Computer Methods and Programs in Biomedicine. ,vol. 27, pp. 223- 228 ,(1988) , 10.1016/0169-2607(88)90086-7
John R. T. Monson, John H. Donohue, Donald C. McIlrath, Michael B. Farnell, Duane M. Ilstrup, Total gastrectomy for advanced cancer. A worthwhile palliative procedure. Cancer. ,vol. 68, pp. 1863- 1868 ,(1991) , 10.1002/1097-0142(19911101)68:9<1863::AID-CNCR2820680902>3.0.CO;2-1
J A Levi, R M Fox, M H Tattersall, R L Woods, D Thomson, G Gill, Analysis of a prospectively randomized comparison of doxorubicin versus 5-fluorouracil, doxorubicin, and BCNU in advanced gastric cancer: implications for future studies. Journal of Clinical Oncology. ,vol. 4, pp. 1348- 1355 ,(1986) , 10.1200/JCO.1986.4.9.1348
John S Macdonald, Philip S Schein, Paul V Woolley, Tarilyn Smythe, Winston Ueno, Daniel Hoth, Frederick Smith, MICHEL BOIRON, CHRISTIAN GISSELBRECHT, RENE BRUNET, CLAUDE LAGARDE, None, 5-Fluorouracil, Doxorubicin, and Mitomycin (FAM) Combination Chemotherapy for Advanced Gastric Cancer Annals of Internal Medicine. ,vol. 93, pp. 533- 536 ,(1980) , 10.7326/0003-4819-93-4-533
Stephen A. Cullinan, A Comparison of Three Chemotherapeutic Regimens in the Treatment of Advanced Pancreatic and Gastric Carcinoma JAMA. ,vol. 253, pp. 2061- 2067 ,(1985) , 10.1001/JAMA.1985.03350380077025
A Lacave, J Wils, H Bleiberg, E Diaz-Rubio, N Duez, O Dalesio, An EORTC Gastrointestinal Group phase III evaluation of combinations of methyl-CCNU, 5-fluorouracil, and adriamycin in advanced gastric cancer. Journal of Clinical Oncology. ,vol. 5, pp. 1387- 1393 ,(1987) , 10.1200/JCO.1987.5.9.1387